IPA alleviates DSS-induced colitis by increasing tight junctions and the muc2-influenced mucus barrier via Pregnane X Receptor (PXR), thereby promoting intestinal barrier integrity while inhibiting TNF-α secretion (Mani and Li, 2015; Lavelle and Sokol, 2020). The gene discussed is TNF; the disease is colitis.